EBS: Emergent BioSolutions Inc. Net earnings per share for the last 12 months

EBS (Emergent Corp) - company brandmark

The Emergent BioSolutions (EBS) biodefense ecosystem relies on US government contracts, although past errors with COVID vaccines created significant risks. The rolling year earnings per share (EPS) visualizes these fluctuations, where -5.09 serves as the current parameter value. Exclusive antidote supplies for strategic reserves guarantee revenue stability, while the growth of Narcan and debt reduction lead to financial recovery.

EBS Emergent Bio Net earnings per share for the last four quarters (07/04/2022 - 11/11/2026)

EBS (Emergent BioSolutions Inc): analytical breakdowns and indicator data

- current quotes and average value forecast:
Price Chart Emergent BioSolutions|EBS - Fair Value Consensus
- market capitalization information:
Market Valuation Emergent BioSolutions Inc.|EBS - Enterprise Value
- balance sheet net asset value indicators:
Net Assets per Single Share Emergent BioSolutions|EBS - Book Valuation of Business|Market Capitalization to Book Value Ratio emergentbiosolutions.com|EBS - Company Assets
- debt level and financial liquidity data:
Debt to Equity Emergent BioSolutions|EBS - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Emergent Corp|EBS - Company Cumulative Debt|Debt to Book Capitalization Ratio Emergent BioSolutions Inc.|EBS - Company Long-Term Loans and Borrowings|Company Short-Term Debts Emergent BioSolutions|Quick Ratio emergentbiosolutions.com
- earnings and multiples data:
EBS - Company Net Income|Expected Profit Emergent BioSolutions|EBS - Price to Earnings Multiple|Projected Price to Earnings Emergent BioSolutions Inc.|EBS - Company Value to Earnings Growth Ratio|Enterprise Value to EBITDA Ratio Emergent BioSolutions Inc.|EBS - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Emergent BioSolutions|EBS - Earnings per share for the last twelve months|Quarterly EPS earnings growth emergentbiosolutions.com|EBS - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year Emergent BioSolutions
Basic company analysis:EBS - Emergent BioSolutions
Mass-produced product of Emergent BioSolutions Inc

The strategic importance of Emergent BioSolutions (EBS) in maintaining the U.S. strategic stockpile mitigates the post-pandemic revenue decline, establishing a foundation for operational resilience. The annual earnings per share trend, reflected in this rolling annual EPS chart, mathematically adjusts net income for the impact of share issuance, enabling investors to promptly identify profitability inflection points and assess the business's intrinsic value.

Competing companies

GILD - Earnings per share for the last twelve months|Earnings per share for the trailing year CDTX (Cidara Therapeutics Inc)|NVAX (Novavax) - Net earnings per share for the last 12 months|CureVac NV (CVAC) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Valneva Pharma|Vir Corp (VIR) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) SIGA|AVIR - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Invivyd IVVD|ENTA - Net earnings per share for the last 12 months|Inovio Pharmaceuticals Inc - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months HilleVax Inc.|Kalaris Therapeutics Inc (KLRS) - Earnings per share for the last twelve months|Dyadic International, Inc. - Earnings per share for the trailing year|NNVC (NanoViricides Inc.) - Net earnings per share (EPS TTM)|TLPH - Net earnings per share for the trailing year|Net earnings per share (EPS TTM) COCP|TRAW - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Dogwood Therapeutics DWTX|QLGN: Earnings per share for the last 12 months|ALVR: Net earnings per share for the last 12 months|VBI Vaccines Inc. - Earnings per share for the last four quarters|VIRI (virios.com) - Net earnings per share for the last 12 months|Vaxart - Earnings per share for the trailing year